Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study
Gut 2009;58:990-7.ArticlePubMed 49
Hesitancy among clinicians about prescribing these injectables and patients taking them should really not be an obstacle
For type 2 diabetes, GLP-1 receptor agonists are typically long-term therapies, similar to blood pressure or cholesterol medications
In a small number of cases, dizziness may indicate an underlying issue requiring clinical assessment
Choline: Exploring the growing science on its benefits for moms and babies
US$ 24.15
US$ 21.58
US$ 21.49
